Allostatic load and chronic pain: a prospective finding from the national survey of midlife development in the United States, 2004–2014

Yunlong Liang,Cara Booker
DOI: https://doi.org/10.1186/s12889-024-17888-1
IF: 4.5
2024-02-09
BMC Public Health
Abstract:Abstract Background Previous research has demonstrated a correlation between chronic stress and chronic pain (CP). However, there have been few studies examining the prospective association of allostatic load (AL)—the biological processes related to stress—with CP. Methods We firstly conducted latent class analysis to identify phenotypes of AL using a community-dwelling sample, the Midlife in the United States. Multinomial logistic regression models were used to examine the prospective association between phenotypes of AL at MIDUS 2 biomarker project and the presence of CP, CP interference and the number of CP sites at MIDUS 3. Results Three phenotypes of AL, low biological dysregulation, parasympathetic dysregulation and metabolic dysregulation, were identified. Compared to low biological dysregulation group, participants experiencing metabolic dysregulation phenotype of AL at MIDUS 2 had higher risks of having high-interference CP (RRR = 2.00, 95% CI: 1.06, 3.79, P < 0.05) and 3 or more CP sites (RRR = 2.03, 95% CI: 1.08, 3.83, P < 0.05) at MIDUS 3. Conclusion The findings indicate that focusing on mitigating the metabolic dysfunction phenotype of AL has the potential to be an efficacious strategy for alleviating future CP bodily widespreadness and high CP interference.
public, environmental & occupational health
What problem does this paper attempt to address?
The paper attempts to address the issue of exploring the prospective association between allostatic load (AL) and chronic pain (CP). Specifically, the study aims to investigate whether different phenotypes of AL are related to the future occurrence of CP, the number of pain sites, and the degree of pain interference through a community-dwelling sample survey. ### Background - **Chronic Pain**: Defined as pain that persists or recurs for more than 3 months, it has become a major global health issue. In the United States, it is estimated that 20.5% of adults suffer from CP each year, imposing a significant burden on the healthcare system and resulting in over $296 billion in productivity losses. - **Allostatic Load**: Refers to the physiological "wear and tear" due to chronic stress adaptation, including the overactivation of the hypothalamic-pituitary-adrenal axis (HPA axis) and the sympathetic nervous system, which can ultimately lead to dysfunction in multiple systems such as cardiovascular, metabolic, and immune systems. ### Research Objectives - **Identify AL Phenotypes**: Identify different phenotypes of AL through latent class analysis (LCA). - **Prospective Association**: Investigate the relationship between these AL phenotypes and the incidence of CP, the number of pain sites, and the degree of pain interference 7 years later. ### Methods - **Data Source**: Data from the Midlife in the United States (MIDUS) study, including the biomarker project from 2004-2009 (MIDUS 2) and the follow-up survey from 2013-2014 (MIDUS 3). - **AL Measurement**: AL was constructed using 27 biomarkers covering seven physiological systems, and LCA was used to identify AL phenotypes. - **CP Measurement**: Included the presence of CP, the degree of pain interference, and the number of pain sites. - **Statistical Analysis**: Multivariable logistic regression and multinomial logistic regression models were used for analysis, and sensitivity analyses were conducted to verify the robustness of the results. ### Results - **AL Phenotypes**: Three AL phenotypes were identified: low biological dysregulation, parasympathetic dysregulation, and metabolic dysregulation. - **Prospective Association**: Compared to the low biological dysregulation group, participants in the metabolic dysregulation group had a higher risk of high interference CP (relative risk ratio RRR = 2.00, 95% CI: 1.06, 3.79, P < 0.05) and a higher risk of having 3 or more pain sites (RRR = 2.03, 95% CI: 1.08, 3.83, P < 0.05) over the next 7 years. ### Conclusion The study results suggest that reducing the AL phenotype of metabolic dysregulation may be an effective strategy to reduce future widespread CP and high interference CP. This provides important scientific evidence for future interventions targeting AL.